Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Chong

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Contraception|February 5, 2020
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestationIlana G Dzuba, Erica Chong, Curtiss Hannum, et al.
Contraception|February 17, 2021
"False positive" urine pregnancy test results after successful medication abortionElizabeth G Raymond, Holly A Anger, Erica Chong, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|September 17, 2016
Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot studySpyros A Kalams, Lisa M Rogers, Rita M Smith, et al.
Contraception|June 7, 2019
TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesElizabeth Raymond, Erica Chong, Beverly Winikoff, et al.
Contraception|March 30, 2021
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemicErica Chong, Tara Shochet, Elizabeth Raymond, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Contraception|February 5, 2020
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestationIlana G Dzuba, Erica Chong, Curtiss Hannum, et al.
Contraception|February 17, 2021
"False positive" urine pregnancy test results after successful medication abortionElizabeth G Raymond, Holly A Anger, Erica Chong, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|September 17, 2016
Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot studySpyros A Kalams, Lisa M Rogers, Rita M Smith, et al.
Contraception|June 7, 2019
TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesElizabeth Raymond, Erica Chong, Beverly Winikoff, et al.
Contraception|March 30, 2021
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemicErica Chong, Tara Shochet, Elizabeth Raymond, et al.
Pageof 3